Page last updated: 2024-08-22

aluminum sulfate and Disease Exacerbation

aluminum sulfate has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achenbach, P; Agardh, CD; Bonifacio, E; Furmaniak, J; Hansen, JM; Hausmann, S; Krause, S; Landherr, U; Lernmark, A; Link, K; Lynch, KF; Powell, M; Rees-Smith, B; Ziegler, AG1
Acevedo, R; Acosta, A; Aguilar, A; Alvarez, N; Borrero, R; Camacho, F; Fernandez, S; Garcia, ML; Hernandez-Pando, R; Kadir, R; Mata Espinoza, D; Norazmi, MN; Payan, JA; Perez, JL; Puig, A; Reyes, F; Sarmiento, ME; Tirado, Y1
Bassi, N; Bottazzi, B; Doria, A; Gatto, M; Ghirardello, A; Luisetto, R; Punzi, L; Shoenfeld, Y1

Trials

1 trial(s) available for aluminum sulfate and Disease Exacerbation

ArticleYear
GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Diabetes care, 2014, Volume: 37, Issue:6

    Topics: Adult; Aged; Alum Compounds; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Disease Progression; Double-Blind Method; Female; Glucose Intolerance; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Male; Middle Aged; Vaccination; Vaccines, Synthetic

2014

Other Studies

2 other study(ies) available for aluminum sulfate and Disease Exacerbation

ArticleYear
Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis model.
    Tuberculosis (Edinburgh, Scotland), 2016, Volume: 101

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Bacterial Load; BCG Vaccine; Disease Models, Animal; Disease Progression; Male; Mice, Inbred BALB C; Mycobacterium smegmatis; Mycobacterium tuberculosis; Pneumonia, Bacterial; Proteolipids; Tuberculosis Vaccines; Tuberculosis, Pulmonary

2016
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant.
    Reumatismo, 2012, Dec-20, Volume: 64, Issue:6

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; C-Reactive Protein; Disease Models, Animal; Disease Progression; DNA; Drug Evaluation, Preclinical; Freund's Adjuvant; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred NZB; Proteinuria; Recombinant Proteins; Serum Amyloid P-Component; Syndrome; Vaccination

2012